Fnx-101

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFnx-101
Drug Alias Nameplasmid based gene therapy (Fenix)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEpidermolysis Bullosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFenix Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFenix Biotech
Active IndicationsN/A
Inactive IndicationsEpidermolysis Bullosa

Other Information

ATC CodeN/A
Related LinksN/A